What if the future of regenerative medicine starts with a few strands of your own hair?

Live from AIS 2026, Dr. Grant Stevens sits down with Acorn CEO Drew Taylor to discuss the company’s progress in developing personalized, autologous exosome-based therapies derived from a patient’s own cells.

Drew explains how Acorn is expanding from topical applications into injectable studies for aesthetic and hair restoration treatments, while also exploring future opportunities in areas ranging from sports medicine to fertility. A compelling look at how regenerative technologies may reshape healthcare in the years ahead.

» Apple Podcasts | https://podcasts.apple.com/us/podcast/technology-of-beauty/id1510898426
» Spotify | https://open.spotify.com/show/0hEIiwccpZUUHuMhlyCOAm
» Recent episodes | https://www.influxmarketing.com/technology-of-beauty/
» Instagram | https://www.instagram.com/thetechnologyofbeauty/
» LinkedIn | https://www.linkedin.com/company/the-technology-of-beauty/

The Technology of Beauty is produced by Influx Marketing, The Digital Agency for Aesthetic Practices. https://www.influxmarketing.com/

Want more aesthetic insights? Subscribe to Next Level Practices, the show where we discuss the ever-changing world of digital marketing and patient acquisition and bring you the latest ideas, strategies, and tactics to help you take your practice to the next level. https://www.influxmarketing.com/next-level-practices/